NEWS CENTER

China Zhongji Invested in "Jiheng Pharmaceutical", Continued to Develop A Big Health

(Summary description)

China Zhongji Invested in "Jiheng Pharmaceutical", Continued to Develop A Big Health

(Summary description)

Information

Recently, China Zhongji completed the equity investment in Hebei Jiheng (Group) Pharmaceutical Co., Ltd. (referred to as "Jiheng Pharmaceutical"). Jiheng Pharmaceutical is a modern large-scale pharmaceutical comprehensive enterprise integrating four series of raw materials, western medicine preparations, traditional Chinese medicine preparations, and pharmaceutical intermediates with 150 varieties. It is a leading domestic acetaminophen raw material  medicine enterprise.

 

 

Jiheng Pharmaceutical was founded in 1996 and is headquartered in Hebei Hengshui New Industrial Zone. It is a wholly-owned subsidiary of Hebei Jiheng Group. The company has the right to import and export its products. The products are sold to 30 domestic provinces, municipalities, autonomous regions and more than 100 countries and regions in South Asia, Southeast Asia, South America, Europe, Africa, etc., and enjoy a good reputation at home and abroad.

 

As a national production base for antipyretic and analgesic APIs, Jiheng Pharmaceutical has a leading position in terms of number of customers, customer quality, and output. The annual production capacity of paracetamol is 25,000 tons, and exports account for 60% to 65 %of the total output, about 11,000 tons per year.

 

Jiheng Pharmaceutical has developed the entire industrial chain production link from p-aminophenol to acetaminophen tablets and granules.

Yang Xiaoying, partner and managing director of China Zhongji Investment, said that Jiheng Pharmaceutical is a well-known enterprise in Hebei, which has been operating steadily over the years and has gradually highlighted its business advantages. The linkage with the chemical sector of Jiheng Group has brought better growth support for Jiheng Pharmaceutical. The emergence of COVID-19 epidemic has brought a new round of growth opportunities for corporate performance. We look forward to the future development of the company. China Zhongji will also continue to focus on outstanding enterprises in Hebei and the pharmaceutical industry, and promote the coordinated development of local and industrial sectors.

Scan the QR code to read on your phone

© 2020 Zhongji Investment All rights reserved  冀ICP备16024224号  冀公网安备 13010802001239号

© 2020 Zhongji Investment All rights reserved  冀ICP备16024224号  冀公网安备 13010802001239号